Buy Tirzepatide Online — 3 sizes (15 mg–60 mg)
Built around incretin receptor pharmacology — metabolic-rate investigations.
Tirzepatide is a synthetic dual agonist of the GIP and GLP-1 receptors — two incretin pathways that collaborate in glucose and energy-balance regulation. Research interest centers on whether dual agonism produces additive or synergistic effects compared with GLP-1-only compounds such as semaglutide.
Vial sizes and price per mg
Up to 33% cheaper per mgReconstitution volumes
Volumes of bacteriostatic water required to dissolve each vial at common research concentrations.
| Vial | at 2 mg/mL | at 5 mg/mL | at 10 mg/mL |
|---|---|---|---|
| 15 mg | 7.50 mL | 3 mL | 1.50 mL |
| 30 mg | 15 mL | 6 mL | 3 mL |
| 60 mg | 30 mL | 12 mL | 6 mL |
Numbers are calculated from the stated vial mass. Verify against the supplier's instructions for your specific research protocol.
Mechanism in the literature
Unlike pure GLP-1 agonists, tirzepatide activates both the GIP (glucose-dependent insulinotropic polypeptide) receptor and the GLP-1 receptor. GIP signaling contributes to insulin release and adipocyte function; the combination is theorized to drive stronger metabolic endpoints at lower GLP-1-driven GI burden.
Research use-cases
- Dual GIP/GLP-1 receptor agonist — a class distinct from semaglutide
- Weekly-dosing research profile, typically studied over 12–40 week windows
- Frequently benchmarked against semaglutide and retatrutide
- Available in 15, 30, and 60 mg research vial sizes
Often paired with
Buyers viewing Tirzepatide typically also consider Adipotide (FTPP), L-Carnitine 5-Pack and 5-Amino-1MQ. Each is in stock, sealed under nitrogen with a lot-matched CoA.
Handling in the lab
Research protocols commonly titrate from low to target concentrations over 4–8 weeks. Reconstitute in bacteriostatic water; a 30 mg vial in 3 mL BAC water yields 10 mg/mL working stock. Aliquot to limit freeze-thaw cycles.
Stacking and paired-compound work
Tirzepatide is usually studied alone in head-to-head comparisons with other incretin compounds. Stacking with cagrilintide or with fat-loss-adjacent compounds like 5-Amino-1MQ appears in some comparative protocols.
Frequently asked
How does tirzepatide differ from semaglutide?
Tirzepatide activates both the GIP and GLP-1 receptors; semaglutide activates only GLP-1. Research studies report stronger metabolic endpoints for tirzepatide in many models.
Why are there 15, 30, and 60 mg vial sizes?
Larger vials reduce per-mg cost for longer studies; smaller sizes suit pilot and titration work.
Is tirzepatide the same as Mounjaro or Zepbound?
Those are commercial pharmaceutical formulations. The material sold here is research-grade and not for human use.
What is a typical reconstitution?
Common research dilutions use 1–3 mL of bacteriostatic water per vial. Aliquot before freezing to reduce freeze-thaw stress.
More Fat Loss compounds
2 sizes-10%
5 sizes-10%
-10%
-10%